GDF15 and soft tissue sarcoma: Following previous reports indicating a modulatory effect of some anticancer drugs on GDF-15 expression (50), we assessed the effects of sirolimus (which is currently considered the best treatment option for patients with EHE) and doxorubicin (the standard first-line chemotherapeutic agent for soft-tissue sarcomas) in our EHE models.